Bionano Genomics, Inc.

LSE:0A4K Stock Report

Market Cap: US$21.0m

Bionano Genomics Management

Management criteria checks 3/4

Bionano Genomics' CEO is Robert Holmlin, appointed in Jan 2011, has a tenure of 13.83 years. total yearly compensation is $1.25M, comprised of 47.7% salary and 52.3% bonuses, including company stock and options. directly owns 0.028% of the company’s shares, worth $5.80K. The average tenure of the management team and the board of directors is 3.5 years and 5.5 years respectively.

Key information

Robert Holmlin

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage47.7%
CEO tenure13.8yrs
CEO ownership0.03%
Management average tenure3.5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Robert Holmlin's remuneration changed compared to Bionano Genomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$136m

Jun 30 2024n/an/a

-US$204m

Mar 31 2024n/an/a

-US$227m

Dec 31 2023US$1mUS$599k

-US$232m

Sep 30 2023n/an/a

-US$227m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$140m

Dec 31 2022US$3mUS$544k

-US$133m

Sep 30 2022n/an/a

-US$117m

Jun 30 2022n/an/a

-US$106m

Mar 31 2022n/an/a

-US$92m

Dec 31 2021US$8mUS$484k

-US$72m

Sep 30 2021n/an/a

-US$61m

Jun 30 2021n/an/a

-US$51m

Mar 31 2021n/an/a

-US$41m

Dec 31 2020US$708kUS$376k

-US$41m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$33m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019US$899kUS$404k

-US$30m

Sep 30 2019n/an/a

-US$28m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$3mUS$390k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$18m

Mar 31 2018n/an/a

-US$22m

Dec 31 2017US$605kUS$379k

-US$23m

Compensation vs Market: Robert's total compensation ($USD1.25M) is above average for companies of similar size in the UK market ($USD356.31K).

Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.

CEO

Robert Holmlin (56 yo)

13.8yrs

Tenure

US$1,254,658

Compensation

Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and served as its Secretary &...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Holmlin
President13.8yrsUS$1.25m0.028%
$ 5.8k
Mark Oldakowski
Chief Operating Officer7yrsUS$884.78k0.020%
$ 4.2k
Alka Chaubey
Chief Medical Officer4.3yrsUS$864.78k0.047%
$ 9.9k
Mark Adamchak
VP of Accounting & Controller6.4yrsno data0.017%
$ 3.6k
Jonathan Dixon
General Counsel & Secretary2.7yrsno data0.019%
$ 3.9k
Stanislas Marin
Vice President of Global Sales2.8yrsno datano data
Donna Polizio
Global Head of Market Access2yrsno datano data
Cory Kreeck
Global Head of People Operations2.8yrsno datano data

3.5yrs

Average Tenure

50.5yo

Average Age

Experienced Management: 0A4K's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Holmlin
President13.8yrsUS$1.25m0.028%
$ 5.8k
Christopher Twomey
Independent Director6.3yrsUS$72.75k0.0067%
$ 1.4k
David Barker
Independent Director14.5yrsUS$97.75k0.0061%
$ 1.3k
Albert Luderer
Independent Chairman13.1yrsUS$77.75kno data
Hannah Mamuszka
Independent Director4.5yrsUS$60.25k0.0069%
$ 1.4k
Kristiina Vuori
Independent Director5.5yrsUS$70.25kno data
Yvonne Linney
Independent Director4.5yrsUS$57.75kno data
Vincent Wong
Independent Director2.9yrsUS$62.75kno data
Aleksandar Rajkovic
Independent Director2.8yrsUS$57.75kno data

5.5yrs

Average Tenure

59yo

Average Age

Experienced Board: 0A4K's board of directors are considered experienced (5.5 years average tenure).